Neelima Denduluri MD, Anne Favret MD, Amy J Irwin MD, OncLive State of Science Summit, Novel Approaches to HER2- Positive Breast Cancer #breastcancer@ndenduluri1@FavretMD @AmyJIrwin
Next to sit down with us was Hernan Vargas, MD, FACS, of @VCSpecialists, who gave an insightful talk about current management strategies of the axilla in #breastcancer. Thank you for the great talk! #bcsm#WorldCancerDay
Great event honoring our 2019 Washingtonian Top Docs, here are a few of them! Keeran Sampat MD, Anne Favret MD & Neelima Denduluri MD Virginia Cancer Specialists @ndenduluri1@FavretMD
Co-Author Dr. Alex Spira @AlexSpiraMDPhD First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors. Monday, June 3,
8:00 AM to 11:00 AM; S406 @ASCO@TheUSONetwork
When people come to you for advice on a decision, resist the urge to give them an answer.
People rarely need to hear your conclusion. They benefit from hearing your thought process and your perspective on the relevant criteria for making the choice.
#WednesdayWisdom
Proud to be included in @asco President’s Circle of Advocacy Champions- https://t.co/3RBJdY3Npt great way to advance patient care! Thanks @RayPageDOPhD@dapattmd@CliffordHudis Dr. Zon Dr. Polite and many others for leading the way!
Co Author Dr. Alex Spira @AlexSpiraMDPhD advancements in #LungCancer treatment options for patients with ALK positive lung cancer! Importance of access to research! Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer | NEJM https://t.co/VGnvDSCump
Dr.Johanna Bendell @SarahCannonDocs giving a tour de force of novel immune agents beyond PD1/PDL1 that target tumor microenvironment, adenosine, arginase - also reminds us #community#cancer#research MATTERS! #USORASF18